Past event: ImmunoTX Summit

PLENARY KEYNOTE SPEAKERS

• Erika Brown, President & Chief Executive Officer, PALTOWN Development Foundation
  
• Scott Durum, Chief, Section of Cytokines and Immunity, NIH - National Cancer Center - Center for Cancer Research
• Gordon Freeman, Professor, Department of Medical Oncology, Professor of Medicine, Dana Farber Cancer Institute, Harvard University
• Michael Karin, Professor, University of California, San Diego
• Andrew Vandergrift, Patient Advocacy Liaison, Ignyta

PLENARY SPEAKERS

• Shawn Baker, Co-Founder and CSO, Allseq
  
• Kevin Murray, Vice President, Global Sales, BioSpherix Medical

Immunogenicity & Immunotoxicity - DISTINGUISHED SPEAKERS

• Gary Bembridge, Senior Director Scientific Affairs, ABZENA
  
• Annie De Groot, Founder, CEO & CSO, Epivax, Inc.
  
• Kei Kishimoto, Chief Scientific Officer, Selecta Biosciences
  
• Eszter Lazar-Molnar, Immunology Medical Director, ARUP Laboratories
  
• Hong-Gee Lee, Senior Product Manager & Technical Support Scientist, PBL Assay Science
• Meina Liang, Director, Clinical Immunology and Bioanalysis, MedImmune
  
• Zuben Sauna, Principal Investigator, Haematology, Research and Review, CBER, FDA
  
• David W. Scott, Professor of Medicine & Vice Chair for Research, Department of Medicine (MED), Uniformed Services University of Health Sciences
• Frances Terry, EpiVax
  
• Albert J Wong, Professor, Cancer Biology Program, Neurosurgery, Stanford University Medical Center

Immunotherapeutics & Immunomonitoring - DISTINGUISHED SPEAKERS

• Maryam Ahmadian, Staff Scientist Gene Expression Laboratory, Salk Institute
  
• Brian Champion, Chief Scientific Officer, PsiOxus Therapeutics
• Preet Chaudhary, Chief, Nohl Division of Hematology, USC
• Deborah Goldberg, Patient, Stage IV Colorectal Cancer Patient
  
• Michael Gresser, Chief Scientific Officer, Immungene
• Ulrich Hoffmueller, CEO, Immune Monitoring Solutions, Epiontis, Precision for Medicine
  
• Karin Jooss, Executive Vice President of Research & Chief Scientific Officer, Gritstone Oncology
• Holly Koblish, Director in the Pharmacology Group, Incyte
• Sean Mackay, CEO, IsoPlexis
  
• Joost Oppenheim, Senior Investigator, NIH NCI
• Alexander Rakhmilevich, Distinguished Scientist, University of Wisconsin-Madison
• Jamie Reno, Investigative Reporter, Healthline Media
  
• Blythe Sather, Associate Director, Juno Therapeutics
  
• Peggy Scherle, Group Vice President of Discovery, Incyte
• Stephen Schoenberger, Laboratory of Cellular Immunology, La Jolla Institute for Allergy and Immunology & UCSD Moores Cancer Center
  
• Steve Siferd, Senior Director, Biopharma Business Development, Cancer Genetics, Inc.
  
• Steffen Walter, Chief Scientific Officer, Immatics

Cytokines & Inflammation - DISTINGUISHED SPEAKERS

• Rachel Caspi, Chief, Immunoregulation Section, NEI, NIH
• Manoj Dadlani, Chief Executive Officer, CosmosID
  
• John Eid, Chief Scientific Officer and Co-Founder, Whole Biome
  
• Ling-Yang Hao, Principal Scientist, Janssen
  
• Michael Howell, Senior Director of Translational Sciences, Incyte Corporation
• Xiao Hu, Executive Director, Lycera Corp
  
• Alison Humbles, Principal Scientist, MedImmune
  
• Ignacio Juncadella, Principal Scientist, Immunology and Respiratory Research, Boehringer Ingelheim
  
• Dermot McGovern, Joshua L. and Lisa Z. Greer Chair of Inflammatory Bowel genetics, Professor of Medicine, Cedars-Sinai Medical Center, UCLA Scool of Medicine
• Kingston HG Mills, Professor of Experimental Immunology, Trinity Biomedical Sciences Institute
• Laurence Morel, Mary and Ryan Whisenant Family Professor of Pathology, University of Florida
• Cathryn Nagler, Bunning Food Allergy Professor, Professor of Pathology, Medicine, Pediatrics and the College, The University of Chicago
  
• Take Ogawa, Director, Business Development, Second Genome
  
• Stanley Perlman, Professor, Microbiology and Immunology, University of Iowa
• Thomas Schall, President and Chief Executive Officer, ChemoCentryx
• Pejman Soroosh, Principal Scientist and Head, Immunobiology Research Team (IRT), Janssen
  
• Howard Spiegel, Simple Plex Specialist, Protein Simple, A Division of Bio-Techne
  

Please fill in your name and email to receive the conference agenda of this event.

Venue

The venue is not yet available for this event.
Follow this event to be informed when the venue is available and stay informed on other changes.

Venue